--2024/Q4-- / 4.131B--
--2024/Q3-- / 4.129B--
Jul 31, 20242024/Q24.164B / 4.045B--
May 8, 20242024/Q13.819B / 3.740B--
Jan 31, 20242023/Q44.457B / 4.010B--
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 18.560
- +0.170+0.92%
Close Aug 23 16:00 ET
- 18.570
- +0.010+0.05%
Post 20:01 ET
21.03BMarket Cap-47589P/E (TTM)
18.570High18.270Low5.13MVolume18.470Open18.390Pre Close94.88MTurnover0.46%Turnover RatioLossP/E (Static)1.13BShares18.58052wk High3.31P/B20.90BFloat Cap8.05552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM1.63%Amplitude3.107Historical Low18.482Avg Price1Lot Size
Teva Pharmaceutical Industries Key Stats
Teva Pharmaceutical Industries Q2 2024 Earnings Date
Currency：USDJul 31, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 4.05B | 4.16B | +118.99M |
| Beat Est. | +4.31% | +7.37% | +2.94% |
| EPS | -0.40 | -0.75 | -0.35 |
| Miss Est. | +47.94% | +3.85% | -87.13% |
Analyst Rating
Aug 23, 2024
Teva Pharmaceutical Industries Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Teva Pharmaceutical Industries Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
